![](/img/cover-not-exists.png)
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
Guarneri, V., Frassoldati, A., Bottini, A., Cagossi, K., Bisagni, G., Sarti, S., Ravaioli, A., Cavanna, L., Giardina, G., Musolino, A., Untch, M., Orlando, L., Artioli, F., Boni, C., Generali, D. G.,Volume:
30
Language:
english
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2011.39.0823
Date:
June, 2012
File:
PDF, 154 KB
english, 2012